Publications by authors named "Jason Madore"

47Publications

Nicotinamide for skin cancer chemoprevention: effects of nicotinamide on melanoma in vitro and in vivo.

Photochem Photobiol Sci 2020 Feb;19(2):171-179

Dermatology, Sydney Cancer Centre, Bosch Institute, The University of Sydney and Royal Prince Alfred Hospital, Camperdown, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c9pp00388fDOI Listing
February 2020

Tumor intrinsic and extrinsic immune functions of CD155.

Semin Cancer Biol 2020 10 26;65:189-196. Epub 2019 Dec 26.

Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, QLD 4006, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2019.11.013DOI Listing
October 2020

Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome.

Oncoimmunology 2019 1;8(5):e1581530. Epub 2019 Mar 1.

Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/2162402X.2019.1
Publisher Site
http://dx.doi.org/10.1080/2162402X.2019.1581530DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492961PMC
March 2019

A Reduction in Inflammatory Macrophages May Contribute to Skin Cancer Chemoprevention by Nicotinamide.

J Invest Dermatol 2019 02 20;139(2):467-469. Epub 2018 Sep 20.

Dermatology, Sydney Cancer Centre, Bosch Institute, The University of Sydney and Royal Prince Alfred Hospital, Camperdown, Sydney, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0022202X183258
Publisher Site
http://dx.doi.org/10.1016/j.jid.2018.08.018DOI Listing
February 2019

Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis.

Cancer Res 2017 09 26;77(17):4684-4696. Epub 2017 Jun 26.

Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-0393DOI Listing
September 2017

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma.

J Thorac Oncol 2017 09 16;12(9):1421-1433. Epub 2017 Jun 16.

Asbestos Diseases Research Institute, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.05.024DOI Listing
September 2017

Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype.

Pathology 2016 Oct 30;48(6):574-80. Epub 2016 Aug 30.

Sydney Medical School, The University of Sydney, Sydney, Australia; South West Clinical School, University of New South Wales, Sydney, Australia; Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2016.07.003DOI Listing
October 2016

PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma.

Clin Cancer Res 2016 08 9;22(15):3915-23. Epub 2016 Mar 9.

Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. Sydney Medical School, The University of Sydney, Camperdown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1714DOI Listing
August 2016

PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma.

Lung Cancer 2015 Aug 18;89(2):181-8. Epub 2015 May 18.

Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.05.007DOI Listing
August 2015

ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype.

Nat Commun 2015 Mar 27;6:6548. Epub 2015 Mar 27.

1] The Kinghorn Cancer Centre &Cancer Research Division, Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia [2] St Vincent's Clinical School, Faculty of Medicine, UNSW, Kensington, New South Wales 2033, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms7548DOI Listing
March 2015

PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials.

Pigment Cell Melanoma Res 2015 May 22;28(3):245-53. Epub 2014 Dec 22.

Melanoma Institute Australia, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/pcmr.12340
Publisher Site
http://dx.doi.org/10.1111/pcmr.12340DOI Listing
May 2015

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.

Lancet Oncol 2013 Aug 9;14(9):853-62. Epub 2013 Jul 9.

Division of Epidemiology, Department of Health Research and Policy, Stanford University, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70253-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006367PMC
August 2013

Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis.

BMC Cancer 2013 Jun 22;13:303. Epub 2013 Jun 22.

Centre de Recherche en Cancérologie de l'Université Laval, Hôpital Hôtel-Dieu de Québec, Quebec City, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-13-303DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708827PMC
June 2013

Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.

Breast Cancer Res 2012 May 8;14(3):R74. Epub 2012 May 8.

Department of Biochemistry, McGill University, Rosalind and Morris Goodman Cancer Research Centre, 3655 Promenade Sir William Osler, Montréal, QC H3G 1Y6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr3183DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446336PMC
May 2012

H3K27 demethylation by JMJD3 at a poised enhancer of anti-apoptotic gene BCL2 determines ERα ligand dependency.

EMBO J 2011 Aug 12;30(19):3947-61. Epub 2011 Aug 12.

Département de Biologie, Faculté des Sciences, Université de Sherbrooke, Sherbrooke, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/emboj.2011.284DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3209777PMC
August 2011

Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma.

J Pathol 2010 Feb;220(3):392-400

Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CHUM)/Institut du Cancer de Montréal, Montréal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.2659DOI Listing
February 2010

Characterization of three new serous epithelial ovarian cancer cell lines.

BMC Cancer 2008 May 28;8:152. Epub 2008 May 28.

Centre de recherche du Centre hospitalier de l'Université de Montréal/Institut du cancer de Montréal, Montreal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-8-152DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2467432PMC
May 2008

An apoptotic molecular network identified by microarray: on the TRAIL to new insights in epithelial ovarian cancer.

Cancer 2007 Jul;110(2):297-308

The Research Centre of the University of Montreal Teaching Hospital (CR-CHUM)/Montreal Cancer Institute, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22812DOI Listing
July 2007

From gene profiling to diagnostic markers: IL-18 and FGF-2 complement CA125 as serum-based markers in epithelial ovarian cancer.

Int J Cancer 2006 Apr;118(7):1750-8

Centre de Recherche du Center Hospitalier de l'Université de Montréal (CR-CHUM), Institut du Cancer de Montréal, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.21521DOI Listing
April 2006